Quince Therapeutics, Inc. - Common Stock (QNCX)
0.0800
-0.0077 (-8.78%)
NASDAQ · Last Trade: Mar 22nd, 11:24 AM EDT
Detailed Quote
| Previous Close | 0.0877 |
|---|---|
| Open | 0.0899 |
| Bid | 0.0842 |
| Ask | 0.0865 |
| Day's Range | 0.0800 - 0.0948 |
| 52 Week Range | 0.0800 - 4.550 |
| Volume | 14,002,688 |
| Market Cap | 2.91M |
| PE Ratio (TTM) | -0.0920 |
| EPS (TTM) | -0.9 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 37,434,203 |
Chart
About Quince Therapeutics, Inc. - Common Stock (QNCX)
Quince Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative treatments for various neurodegenerative diseases and chronic conditions. The company leverages advanced scientific research and technology to create therapies that aim to improve patient outcomes and enhance quality of life. With a strong commitment to addressing unmet medical needs, Quince Therapeutics works on the development of novel drugs that target the underlying mechanisms of disease, thereby offering hope for patients diagnosed with serious health challenges. Read More
News & Press Releases
Curious about the most active stocks on Thursday?chartmill.com
Via Chartmill · March 5, 2026
These stocks are the most active in today's sessionchartmill.com
Via Chartmill · February 25, 2026
Discover the most active stocks in Wednesday's session.chartmill.com
Via Chartmill · February 18, 2026
Unusual volume stocks are being observed in Wednesday's session.chartmill.com
Via Chartmill · February 18, 2026
These stocks are making the most noise in today's session.chartmill.com
Via Chartmill · February 17, 2026
Discover the most active stocks in Friday's session.chartmill.com
Via Chartmill · February 13, 2026
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · February 13, 2026
Which stocks are moving on Thursday?chartmill.com
Via Chartmill · February 12, 2026
These stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · February 12, 2026
Which stocks are experiencing notable movement on Thursday?chartmill.com
Via Chartmill · February 12, 2026
There are notable gap-ups and gap-downs in today's session.chartmill.com
Via Chartmill · February 12, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · February 12, 2026
As investors continue scanning the small-cap landscape for high-upside opportunities, a select group of stocks under $1 is drawing renewed market attention across semiconductors, media, environmental services, biotechnology, and education technology. With volatility creating opportunity in the micro-cap space, these companies are emerging as speculative names to watch.
Via AB Newswire · February 11, 2026
Curious about the most active stocks on Wednesday?chartmill.com
Via Chartmill · February 11, 2026
On Wednesday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · February 11, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · February 11, 2026
Get insights into the top gainers and losers of Wednesday's pre-market session.chartmill.com
Via Chartmill · February 11, 2026
These stocks are making the most noise in today's session.chartmill.com
Via Chartmill · February 10, 2026
These stocks are gapping in today's sessionchartmill.com
Via Chartmill · February 10, 2026
Top movers in Tuesday's pre-market sessionchartmill.com
Via Chartmill · February 10, 2026
The company announced that it has appointed LifeSci Capital as its exclusive financial advisor to support a restructuring effort and review strategic alternatives.
Via Stocktwits · February 10, 2026
Quince Therapeutics (NASDAQ: QNCX) engages LifeSci as financial advisor to explore strategic alternatives. Stock jumps.
Via Benzinga · February 10, 2026
Monday's after hours session: top gainers and loserschartmill.com
Via Chartmill · February 9, 2026
Quince Therapeutics, Inc. (Nasdaq: QNCX), today announced that it has engaged LifeSci Capital to serve as its exclusive financial advisor to assist in its restructuring and evaluation of strategic alternatives aimed at maximizing shareholder value.
By Quince Therapeutics, Inc. · Via Business Wire · February 9, 2026